Shareholders of Israeli technology firm Elbit last week approvedthe Haifa company's acquisition of the Elscintec ultrasound businessof Elscint, an Elbit subsidiary. Elbit proposed the acquisitionlate last year (SCAN 12/27/95). Elbit continues to study a
Shareholders of Israeli technology firm Elbit last week approved
the Haifa company's acquisition of the Elscintec ultrasound business
of Elscint, an Elbit subsidiary. Elbit proposed the acquisition
late last year (SCAN 12/27/95). Elbit continues to study a plan
to spin off Elbit into three separate firms, including one that
would consolidate the healthcare operations of Elbit and Elscint.
Study: AI Bolsters Sensitivity for Pneumothorax on CXR and Significantly Reduces Reporting Time
October 30th 2024For clinically actionable pneumothorax, an artificial intelligence algorithm demonstrated a 93 percent AUC and a 96 percent specificity rate in a study involving chest X-rays from over 27,000 adults.
AI Segmentation, Intraprostatic Tumor Volume and Metastases: What a New mpMRI Study Reveals
October 29th 2024For patients who received radiotherapy for localized prostate cancer, total intraprostatic tumor volume derived from AI segmentation had a 10 percent higher AUC for predicting seven-year metastases in comparison to a risk model from the National Comprehensive Cancer Network (NCCN).
Study: AI Bolsters Sensitivity for Pneumothorax on CXR and Significantly Reduces Reporting Time
October 30th 2024For clinically actionable pneumothorax, an artificial intelligence algorithm demonstrated a 93 percent AUC and a 96 percent specificity rate in a study involving chest X-rays from over 27,000 adults.
AI Segmentation, Intraprostatic Tumor Volume and Metastases: What a New mpMRI Study Reveals
October 29th 2024For patients who received radiotherapy for localized prostate cancer, total intraprostatic tumor volume derived from AI segmentation had a 10 percent higher AUC for predicting seven-year metastases in comparison to a risk model from the National Comprehensive Cancer Network (NCCN).
2 Commerce Drive
Cranbury, NJ 08512